Christopher Yea, Chief Development Officer: KalVista Pharmaceuticals KALV Sell · Filed 05/26

Trade details

Type: Insider sale
Amount: $63,147.24
Shares · price: 2,358 sh · $26.78 a share
Held after: 228,759 sh
Stock: KalVista Pharmaceuticals KALV
Person: Christopher YeaChief Development Officer
Trade date: 26/05/22
Filed: 26/05/26
Days to filing: 4 days

Sold 1.0% of holdings

Share of holding sold: 1.0%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 04/22~06/21

Christopher Yea's recent trades

Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$905.2K
33,800 sh
$905.2K
Filed 05/29
Traded 05/27
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$52.6K
1,966 sh
$52.6K
Filed 05/27
Traded 05/26
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$29.7K
1,108 sh
$29.7K
Filed 05/19
Traded 05/18
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$67.7K
4,347 sh
$67.7K
Filed 02/24
Traded 02/23
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$16.6K
1,109 sh
$16.6K
Filed 02/19
Traded 02/18